2012
DOI: 10.2147/ijn.s28279
|View full text |Cite
|
Sign up to set email alerts
|

Correlation between radioactivity and chemotherapeutics of the 111In-VNB-liposome in pharmacokinetics and biodistribution in rats

Abstract: Background The combination of a radioisotope with a chemotherapeutic agent in a liposomal carrier (ie, Indium-111-labeled polyethylene glycol pegylated liposomal vinorelbine, [ 111 In-VNB-liposome]) has been reported to show better therapeutic efficiency in tumor growth suppression. Nevertheless, the challenge remains as to whether this therapeutic effect is attributable to the combination of a radioisotope with chemotherapeutics. The goal of this study was to investigat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 30 publications
0
2
0
Order By: Relevance
“…In 2008, our team loaded liposomes with the radioactive 111 In and the chemotherapeutic VNB and compared the therapeutic effects of them with other potential combinations (39). In 2012, the overall efficacies of the 111 In-VNB-liposomes were investigated in a rat model with a perfect correlation between the pharmacokinetics and biodistribution (52). In the current study, we made a further modification by reducing the dose of the chemotherapeutic drugs from 5 mg/kg to 3 mg/kg and re-evaluated the overall efficacy from single dose to multiple doses.…”
Section: Discussionmentioning
confidence: 99%
“…In 2008, our team loaded liposomes with the radioactive 111 In and the chemotherapeutic VNB and compared the therapeutic effects of them with other potential combinations (39). In 2012, the overall efficacies of the 111 In-VNB-liposomes were investigated in a rat model with a perfect correlation between the pharmacokinetics and biodistribution (52). In the current study, we made a further modification by reducing the dose of the chemotherapeutic drugs from 5 mg/kg to 3 mg/kg and re-evaluated the overall efficacy from single dose to multiple doses.…”
Section: Discussionmentioning
confidence: 99%
“…Because vinorelbine is well known to cause venous irritation and phlebitis when directly administered intravenously, [ 89 - 92 ] new drug delivery systems are urgently required. [ 89 - 93 ]…”
Section: Vinorelbinementioning
confidence: 99%